Ep 278 - Armor Medical’s wearable could give earlier warnings of severe hemorrhaging before it’s too late

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall. This episode is sponsored by DeviceTalks Minnesota. Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific. Grand also introduced MedTech Innovator’s Radar Forum: https://medtechinnovator.org/radarforum2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedTech Innovator Radar Forum(00:12:06) - Pharaoh Neuro raises $20M, names former Medtronic exec as CEO(00:15:05) - Medtronic MiniMed Diabetes unit prices IPO at up to $784M(00:20:40) - Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software(00:22:50) - AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker(00:24:56) - Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit(00:34:13) - Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical